Skip to main content

Table 6 RDT proficiency among laboratory and ANC staff in health facilities in the ISTp-DP arm

From: Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya

Intermediate process

Lab

ANC

 

n

Intermediate process effectiveness

Cumulative delivery effective-ness

n

Intermediate process effective-ness ± 

Cumulative delivery effective-ness ≠ 

Difference (Intermed-iate processes), %

  

% (95% CI)

%

 

% (95% CI)

%

 

RDT performed

 1. 2nd and 3rd trimestera

289

90.3 (70.7, 97.3)

90.3

289

90.3 (70.7, 97.3)

90.3

0

  2. RDT performed ANC or lab

15

5.2 (0.6, 34.7)

90.3

274

94.8 (65.3, 99.4)

90.3

0

 3. Gloves worn

11

73.3 (34.9, 93.4)

66.2

129

47.1 (13.8, 83.2)

42.5

-26.2

 4. RDT opened in front woman

11

100

66.2

126

97.7 (78.1, 99.8)

41.5

-2.3

 5. Fourth finger selected

4

36.4 (1.5, 95.6)

24.1

82

65.1 (51.1, 76.9)

27

 + 28.7

 6a. Finger cleaned with alcohol

4

100

24.1

79

96.3 (76.4, 99.5)

26

-3.7

 6b. Without step 5

11

100

66.2

117

92.9 (76.9, 98.1)

40

-7.1

 7. RDT labelled patient’s name

10

90.9 (0.0, 100.0)

60.2

26

22.2 (10.5, 41.1)

8.9

-68.7

 8a. Correct volume/ml blood added

10

100

60.2

26

100

8.9

0

 8b. Without step 7

11

100

66.2

117

100

40

0

 9. Blood added to correct place

11

100

66.2

117

100

40

0

 10. Buffer added after blood

11

100

66.2

117

100

40

0

 11. Buffer added correct place

11

100

66.2

117

100

40

0

 12. > 20 < 35 min waiting time

6

54.5 (0.7, 99.5)

36.1

35

29.9 (13.7, 53.4)

12

− 24.6

 13. Control line visible

6

100

36.1

35

100

12

0

 14. RDT result read accurately

6

100

36.1

35

100

12

0

 15. Result given to women

6

100

36.1

35

100

12

0

16. Guidelines used

0

0

0

4

11.4 (0.3, 83.4)

1.4

+ 11.4

  1. aIncludes 6 missing trimester